Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/19944
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKostic, Marina-
dc.contributor.authorMarjanović, Jovana S-
dc.contributor.authorDivac, Vera-
dc.date.accessioned2024-01-18T08:24:00Z-
dc.date.available2024-01-18T08:24:00Z-
dc.date.issued2023-
dc.identifier.citationKostić, M.D.; Divac, V.M.; Marjanović, J.S. ADME/drug-likeness properties of three vanillin-based Schiff bases†, in Proceedings of the 9th International Electronic Conference on Medicinal Chemistry, 1–30 November 2023, MDPI: Basel, Switzerlanden_US
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/19944-
dc.description.abstractHerein we present the results obtained in the in silico ADME screening and drug-likeness evaluation of three Schiff bases based on vanillin aldehyde. As an amine counterpart, the selenourea, urea and thiourea were used. According to the obtained results, all three compounds have demonstrated optimal lipophilicity and moderate solubility necessary for the achievement of good bioavailability when administrated orally. Ii was also observed that all compounds have potential to be well absorbed into systematic circulation in GIT (gastrointestinal tract), without possibility to cross blood-brain barrier. The urea-based compound has showed no potential to inhibit any of five P450 isoform. The target screening has indicated that the family of cytosolic proteins and enzymes were the most probable physiological targets for the screened compounds.en_US
dc.language.isoenen_US
dc.publisherMDPI, Basel, Switzerlanden_US
dc.rightsCC0 1.0 Universal*
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.subjectADMEen_US
dc.subjectSchiff basesen_US
dc.subjectvanillinen_US
dc.titleADME/drug-likeness properties of three vanillin-based Schiff basesen_US
dc.typeconferenceObjecten_US
dc.description.versionPublisheden_US
dc.identifier.doi10.3390/ECMC2023-16711en_US
dc.relation.conferenceThe 9th International Electronic Conference on Medicinal Chemistry (ECMC 2023)en_US
dc.type.versionPublishedVersionen_US
Appears in Collections:Institute for Information Technologies, Kragujevac

Page views(s)

21

Downloads(s)

12

Files in This Item:
File Description SizeFormat 
Marina Kostic - ECMC 2023.pdf822.68 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons